Judge: Theresa M. Traber, Case: 19STCV06421, Date: 2023-02-21 Tentative Ruling
Case Number: 19STCV06421 Hearing Date: February 21, 2023 Dept: 47
Tentative Ruling
Judge Theresa M. Traber, Department 47
HEARING DATE: February 21, 2023 TRIAL DATE: April 18, 2023
CASE: James Lewallen, et al. v. Does 1 through
100
CASE NO.: 19STCV06421
![]()
MOTION
FOR SUMMARY JUDGMENT
![]()
MOVING PARTY: Defendant Durapax, LLC. (Doe 32)
RESPONDING PARTY(S): Plaintiffs James
Lewallen and Carole Lewallen
CASE
HISTORY:
Henry Company LLC
substituted in as Doe 2.
ITW Polymers
Sealants North America Inc. substituted in as Doe 3.
MBTechnology
substituted in as Doe 4.
Smalley &
Company substituted in as Doe 5.
Sunshine Supply
Co., Inc. substituted in as Doe 6.
Top Industrial,
Inc. substituted in as Doe 7.
Tropical Roofing
Products of California, LLC substituted in as Doe 8.
Bostik, Inc. substituted in as Doe
10.
Carlisle Coatings and
Waterproofing Inc. substituted in as Doe 11.
Certainteed Corporation
substituted in as Doe 12.
Brenntag Canada Inc. substituted
in as Doe 13.
Minerals Technologies Inc.
substituted in as Doe 14.
Concrete Sealants, Inc. substituted in as Doe 15.
GAF Materials LLC
substituted in as Doe 16.
GP Gypsum LLC
substituted in as Doe 17.
W.R. Grace &
Co.-Conn. substituted in as Doe 18.
W.M. Barr &
Company, Inc. substituted in as Doe 19.
Citgo Petroleum
Corporation substituted in as Doe 20.
Mule-Hide
Products Co., Inc. substituted in as Doe 21.
Nemeon, Inc.
substituted in as Doe 22.
Sika Corporation
substituted in as Doe 23.
TAMKO Building
Products, Inc. substituted in as Doe 24.
Tremco
Incorporated substituted in as Doe 25.
Doe 26.
Vance Brothers,
Inc. substituted in as Doe 28.
Soprema U.S.A.,
Inc. substituted in as Doe 29.
Xypex Chemical
Corporation substituted in as Doe 30.
Owens Corning
substituted in as Doe 31.
Durapax LLC
substituted in as Doe 32.
STATEMENT
OF MATERIAL FACTS AND/OR PROCEEDINGS:
This is a toxic tort case.
Plaintiffs allege that Plaintiffs James Lewallen, who worked in the
construction industry in various capacities, was exposed to toxic chemical
products manufactured, distributed, or supplied by the Defendants and sustained
injuries as a result, including lung cancer.
Defendant Durapax,
LLC moves for summary judgment.
TENTATIVE RULING:
Defendant Durapax, LLC’s motion for
summary judgment is GRANTED.
DISCUSSION:
Defendant
moves for summary judgment on the basis that Plaintiff cannot establish
causation on the part of the moving Defendant.
//
Legal Standard
The function of a motion for
summary judgment or adjudication is to allow a determination as to whether an
opposing party can show evidentiary support for a pleading or claim and, if
not, to enable an order of summary dismissal without the need for trial. (Aguilar
v. Atlantic Richfield Co. (2001) 25 Cal.4th 826, 843.) Code of Civil
Procedure Section 437c(c) “requires the trial judge to grant summary judgment
if all the evidence submitted, and ‘all inferences reasonably deducible from
the evidence’ and uncontradicted by other inferences or evidence, show that
there is no triable issue as to any material fact and that the moving party is
entitled to judgment as a matter of law.”
(Adler v. Manor Healthcare Corp. (1992) 7 Cal.App.4th 1110,
1119.) “The function of the pleadings in
a motion for summary judgment is to delimit the scope of the issues; the
function of the affidavits or declarations is to disclose whether there is any
triable issue of fact within the issues delimited by the pleadings.” (Juge
v. County of Sacramento (1993) 12 Cal.App.4th 59, 67, citing FPI
Development, Inc. v. Nakashima (1991) 231 Cal. App. 3d 367, 381-82.)
As to each claim as framed by the
complaint, the defendant moving for summary judgment must satisfy the initial
burden of proof by presenting facts to negate an essential element, or to
establish a defense. (Code Civ Proc. § 437c(p)(2); Scalf v. D. B. Log Homes,
Inc. (2005) 128 Cal.App.4th 1510, 1520.) Courts “liberally construe the
evidence in support of the party opposing summary judgment and resolve doubts
concerning the evidence in favor of that party.” (Dore v. Arnold Worldwide,
Inc. (2006) 39 Cal.4th 384, 389.) The lack of opposition by a plaintiff is
not grounds to grant a motion for summary judgment if a defendant cannot meet
their initial burden of proof. (See Thatcher v. Lucy Stores, Inc. (2000)
79 Cal.App.4th 1081, 1087.)
Once the
defendant has met that burden, the burden shifts to the plaintiff to show that
a triable issue of one or more material facts exists as to that cause of action
or a defense thereto. To establish a triable issue of material fact, the party
opposing the motion must produce substantial responsive evidence. (Sangster
v. Paetkau (1998) 68 Cal.App.4th 151, 166.)
Defendant’s Evidentiary Objections
Defendant
raises evidentiary objections to the Declarations of Robert Harrison and
Raphael Metzger in support of the opposition papers. As the Court does not rely
on these documents in reaching its ruling, the Court declines to rule on these
objections. (Code Civ. Proc. § 437c(q).)
Analysis
Defendant
moves for summary judgment on the basis that Plaintiffs cannot establish
causation on the part of the moving Defendant.
In a toxic tort
case based on occupational exposure involving multiple defendants and multiple
products, to show causation, Plaintiffs must show that the “exposure to a
particular defendant’s product was a “substantial factor contributing to
Plaintiffs’ . . . risk of developing” lung disease. (Cf. Rutherford v.
Owens-Illinois, Inc. (1997) 16 Cal.4th 953, 977 [announcing this standard
in a case involving cancer caused by asbestos exposure].) The “substantial
factor standard is a relatively broad one, requiring only that the contribution
of the individual cause be more than negligible or theoretical.” (Id. at
978.) Thus, “each of several actors or forces acting concurrently to cause an
injury is the legal cause of the injury ‘regardless of the extent to which each
contributes to the injury.’” (Ibid. [quoting BAJI No. 3.77].)
Defendant argues that
Plaintiffs cannot establish exposure to any of Defendant’s products such that Defendant
could be liable for Mr. Lewallen’s cancer. The Complaint, as amended, alleges
that Plaintiff James Lewallen was exposed to toxic compounds from Defendant’s LiquidPitch
and Coal Tar Roofing Pitch products. (November 1, 2019 Amendment to Complaint.)
Defendant states that, although Plaintiff initially testified that he encountered
Defendant’s products while working as an inspector for All American, Plaintiff
subsequently recanted his testimony in both written interrogatories and
subsequent deposition testimony. (Defendant’s Separate Statement of Undisputed
Material Fact Nos. 10-12.) Further, while Defendant concedes that Plaintiff stated
broadly in written discovery responses that he was exposed to Defendant’s
products while working for Van Dijk and Associates (SSUMF No. 8), defense counsel
attests in his declaration to being unable to locate any reference to Defendant
or its products in Van Dijk’s work orders, which were identified by Plaintiffs
as documents supporting their allegations. (SSUMF Nos. 18-19.) Defendant
provided a declaration under penalty of perjury by Defendant’s counsel that no
reference to Durapax or its product was located in the records, but did not actually
provide the records themselves. (Defendant’s Exhibit J.) Defendant also offers Nils
Van Dijk’s testimony that he had not heard of Durapax and had no information
that Plaintiff ever worked at a site where Durapax products were present.
(SSUMF No. 14.) Defendant further
challenges Plaintiffs’ claims as to exposure while working for Van Dijk by
stating that the only other supporting evidence was Plaintiff’s testimony that
he heard an anonymous individual mention the name “Durapax.” (SSUMF No. 13.)
Defendant contends that this statement is inadmissible hearsay.
The Court
is persuaded that the evidence offered by Defendant is sufficient to meet its
initial burden on summary judgment. Defendant has offered evidence, by way of
Plaintiff James Lewallen’s admissions in deposition testimony, that Plaintiff
was not exposed to any of Defendant’s products during his employment at All
American. Plaintiffs initially offered evidence under penalty of perjury that Mr.
Lewallen worked with Durapax products during his time at Van Dijk and Associates
and identified documents supporting that contention. In response, Defendants
have offered evidence, by way of a declaration of counsel summarizing the
documents, that the documents in question do not support that claim. Section
1523, subdivision (d), of the Evidence Code expressly permits oral testimony of
the content of a writing if “the writing consists of numerous accounts for
other writings that cannot be examined in court without great loss of time, and
the evidence sought from them is only the general result of the whole.” (See
Heaps v. Heaps (2004) 124 Cal.App.4th 286, 294.) A declaration of counsel,
like the one submitted by Defendant here, is properly considered by the court
because the summary motion procedure authorizes the trial court to rely upon
declarations. (Code Civ. Proc. § 437c(b)(1).) Further, Mr. Lewallen’s
subsequent deposition testimony appears to show that he did not actually use
with or inspect any Durapax products during his employment at Van Dijk &
Associates. (See Defendant’s Exh. H pp. 584:5-585:11.) Taken in aggregate, this
evidence demonstrates that Durapax’s products were not present at any of the
sites Mr. Lewallen inspected and, therefore, that Plaintiffs cannot establish
that Durapax caused Mr. Lewallen’s injuries. The burden now shifts to
Plaintiffs to demonstrate a triable issue of fact on the question of causation.
Plaintiffs’
primary argument in opposition is that Defendant failed to meet its initial
burden. As the Court has reached the opposite conclusion, this argument is
necessarily unpersuasive. On the question of whether there are triable issues
of fact, Plaintiffs advance only a single paragraph of arguments identifying
potential issues of fact that are not related to the question of whether
Durapax products were ever present at any of the sites Plaintiff inspected. Nor
do Plaintiffs submit any new evidence in their separate statement, instead
pointing to the same initial deposition testimony where Mr. Lewallen said that
he thought he encountered the name Durapax when working for All American, but
this is the same testimony which Plaintiff recanted in his later deposition. Plaintiffs
also argue that the work orders are not dispositive because, if Mr. Lewallen
did encounter the product while working for Van Dijk & Associates, it was
“likely early in his employment with Van Dijk at a time when Van Dijk no longer
has records, or was in his work as a roofing construction worker before Van
Dijk.” (Separate Statement of Disputed Fact No. 19.) But Plaintiffs do not offer any admissible
evidence of these assertions, as they are required to do on summary judgment.
Faced with this absence of evidence, the Court must conclude that Plaintiffs failed
to demonstrate the existence of a triable issue of fact on the question of
causation. Defendant is therefore entitled to summary judgment as a matter of
law.
CONCLUSION:
Accordingly, Defendant Durapax, LLC’s motion for summary judgment
is GRANTED.
Moving Party to give notice.
IT IS SO ORDERED.
Dated: February 21,
2023 ___________________________________
Theresa
M. Traber
Judge
of the Superior Court
Any party may submit on the
tentative ruling by contacting the courtroom via email at Smcdept47@lacourt.org by no later
than 4:00 p.m. the day before the hearing. All interested parties
must be copied on the email. It should be noted that if you submit
on a tentative ruling the court will still conduct a hearing if any party
appears. By submitting on the tentative you have, in essence, waived your right
to be present at the hearing, and you should be aware that the court may not
adopt the tentative, and may issue an order which modifies the tentative ruling
in whole or in part.